Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure

Prostate Cancer and Prostatic Diseases volume 28, pages 832–833 (2025)Cite this article

Subjects

Abstract

Background/Objectives

Endorsing the principles of minimal invasiveness in benign-prostatic hyperplasia (BPH) surgery, we conducted the first evaluation of transurethral intraprostatic anesthesia (TUIA) using Schelin catheter® (SC) prior to iTIND positioning.

Subjects/Methods

Of 23 patients enrolled, 11 (48%) received TUIA via SC whereas the remaining underwent standard anesthesia protocol. Pain was assessed using visual analogue scale (VAS).

Results

No differences between cohorts were observed for pain during the device implantation and removal. Conversely, significantly lower median VAS scores were reported at 24- (1.0 vs. 3.0) and 48- (1.0 vs. 2.5) hour follow-up favoring TUIA.

Conclusions

SC TUIA offers effective pain control during iTIND procedures, supporting its use in outpatient settings.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Median visual analouge scale (VAS) pain scores over time.

Similar content being viewed by others

Data availability

The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding author.

References

  1. Nguyen DD, Li T, Ferreira R, Baker Berjaoui M, Nguyen ALV, Chughtai B, et al. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation. Prostate Cancer Prostatic Dis. 2023;27:22–8.

    Article  PubMed  Google Scholar 

  2. Manfredi C, Arcaniolo D, Spatafora P, Crocerossa F, Fusco F, Verze P, et al. Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications. Minerva Urol Nephrol. 2022;74:389–99.

    Article  PubMed  Google Scholar 

  3. Amparore D, Fiori C, Valerio M, Schulman C, Giannakis I, De Cillis S, et al. 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2020;24:349–57.

    Article  PubMed  Google Scholar 

  4. Amparore D, De Cillis S, Schulman C, Kadner G, Fiori C, Porpiglia F. Temporary implantable nitinol device for benign prostatic hyperplasia-related lower urinary tract symptoms: over 48-month results. Minerva Urol Nephrol. 2023;75:743–51.

    Article  PubMed  Google Scholar 

  5. Sibona M, Destefanis P, Vercelli E, Secco S, Gontero P, Cindolo L. Ejaculation physiology and dysfunction after BPH surgery: the role of the new MISTs. Prostate Cancer Prostatic Dis. 2023;26:475–82.

    Article  PubMed  Google Scholar 

  6. Gemma L, Pecoraro A, Sebastianelli A, Spatafora P, Sessa F, Nicoletti R, et al. Impact of minimally invasive surgical procedures for Male Lower Urinary Tract Symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review. Prostate Cancer Prostatic Dis. 2024;27:404–21.

    Article  PubMed  Google Scholar 

  7. Tzeng M, Basourakos SP, Lewicki PJ, Hu JC, Lee RK. New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review. Eur Urol Focus. 2022;8:522–31.

    Article  PubMed  Google Scholar 

  8. Schelin S. Transurethral resection of the prostate after intraprostatic injections of mepivacain epinephrine: a preliminary communication. Scand J Urol Nephrol. 2009;43:63–67.

    Article  CAS  PubMed  Google Scholar 

  9. Hamouda A, Ibrahim A, Corsi N, Siena G, Elterman DS, Chughtai B et al. Use of the Schelin Catheter for transurethral intraprostatic anesthesia prior to Rezūm treatment. Can J Urol. 2024;31. www.canjurol.com.

  10. Siena G, Sessa F, Cindolo L. Use of a Schelin Catheter for analgesia during Rezum treatment of the prostate. Prostate Cancer Prostatic Dis. 2024;27:147–9.

    Article  CAS  PubMed  Google Scholar 

  11. Gravas S, Malde S, Cornu JN, Gacci M, Gratzke C, Herrmann TRW, et al. From BPH to male LUTS: a 20-year journey of the EAU guidelines. Prostate Cancer Prostatic Dis. 2023;27:48–53.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

    Silvia Secco, Alberto Olivero, Paolo Dell’Oglio, Stefano Tappero, Edoardo Dibilio, Tommaso Saccucci, Aldo Massimo Bocciardi & Antonio Galfano

  2. Unit of Urology/Division of Oncology, Gianfranco Soldera Prostate Cancer Lab, IRCCS Ospedale San Raffaele, Milan, Italy

    Mattia Longoni

  3. Vita-Salute San Raffaele University, Milan, Italy

    Mattia Longoni

  4. Unit of Oncologic Minimally Invasive Urology and Andrology, Careggi University Hospital, Florence, Italy

    Giampaolo Siena

  5. Department of Urology, Villa Stuart Private Hospital, Rome, Italy

    Luca Cindolo

Authors
  1. Silvia Secco
    View author publications

    Search author on:PubMed Google Scholar

  2. Alberto Olivero
    View author publications

    Search author on:PubMed Google Scholar

  3. Mattia Longoni
    View author publications

    Search author on:PubMed Google Scholar

  4. Paolo Dell’Oglio
    View author publications

    Search author on:PubMed Google Scholar

  5. Stefano Tappero
    View author publications

    Search author on:PubMed Google Scholar

  6. Edoardo Dibilio
    View author publications

    Search author on:PubMed Google Scholar

  7. Tommaso Saccucci
    View author publications

    Search author on:PubMed Google Scholar

  8. Giampaolo Siena
    View author publications

    Search author on:PubMed Google Scholar

  9. Aldo Massimo Bocciardi
    View author publications

    Search author on:PubMed Google Scholar

  10. Antonio Galfano
    View author publications

    Search author on:PubMed Google Scholar

  11. Luca Cindolo
    View author publications

    Search author on:PubMed Google Scholar

Contributions

SS: project development, data collection, drafting of the manuscript; AO: project development, data collection; ML: data analysis, drafting of the manuscript; PD: data collection; ST: data collection, ED: critical revision of the manuscript; TS: critical revision of the manuscript; GS: critical revision of the manuscript; AMB; critical revision of the manuscript; AG: critical revision of the manuscript; LC: project development, critical revision of the manuscript, drafting of the manuscript.

Corresponding author

Correspondence to Silvia Secco.

Ethics declarations

Competing interests

AO, ML, PD, ST, ED, TS, GS, AMB, AG, LC: no conflicts of interest to declare; SS: proctor iTIND (Medi-Tate LTd.®, Or Akiva, Israel).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Secco, S., Olivero, A., Longoni, M. et al. Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure. Prostate Cancer Prostatic Dis 28, 832–833 (2025). https://doi.org/10.1038/s41391-024-00892-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41391-024-00892-2

This article is cited by

Search

Advanced search

Quick links